Skip to content
10-Q

Quarterly Report

FluoroPharma Medical, Inc.

0001415889-16-005925

← back to feed
Filed
May 16, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · May 13, 2016 33.35M sh
Operating Cash Flow Q1 2016 · Mar 31, 2016 −$393.82K
Operating Cash Flow Q1 2016 · Mar 31, 2015 −$390.21K
Cash And Equivalents Q1 2016 · Mar 31, 2016 $41.17K
Cash And Equivalents Q1 2016 · Dec 31, 2015 $290.85K
Cash And Equivalents Q1 2016 · Mar 31, 2015 $85.96K
Cash And Equivalents Q1 2016 · Dec 31, 2014 $252.15K
Stockholders Equity Q1 2016 · Mar 31, 2016 −$9.45M
Stockholders Equity Q1 2016 · Dec 31, 2015 −$7.86M
Current Liabilities Q1 2016 · Mar 31, 2016 $9.91M
Current Liabilities Q1 2016 · Dec 31, 2015 $8.7M
Current Assets Q1 2016 · Mar 31, 2016 $138.21K
Current Assets Q1 2016 · Dec 31, 2015 $509K
Total Assets Q1 2016 · Mar 31, 2016 $456.86K
Total Assets Q1 2016 · Dec 31, 2015 $838.6K
Eps Basic Q1 2016 · Mar 31, 2016 −$0.05
Eps Basic Q1 2016 · Mar 31, 2015 −$0.02
Sga Expense Q1 2016 · Mar 31, 2016 $492.31K
Sga Expense Q1 2016 · Mar 31, 2015 $678.64K
Rd Expense Q1 2016 · Mar 31, 2016 $189.66K
Rd Expense Q1 2016 · Mar 31, 2015 $182.41K
Net Income Q1 2016 · Mar 31, 2016 −$1.57M
Net Income Q1 2016 · Mar 31, 2015 −$574.1K
Operating Income Q1 2016 · Mar 31, 2016 −$681.97K
Operating Income Q1 2016 · Mar 31, 2015 −$861.04K